{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:28:18Z","timestamp":1785180498472,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Colombiana de Psiquiatr\u00eda"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.rcp.2019.07.002","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T07:58:27Z","timestamp":1580716707000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabinoids for major neurocognitive disorder: case report and literature review"],"prefix":"10.1016","volume":"50","author":[{"given":"Paula M.","family":"Herrera G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Ochoa-Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Jaramillo Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcp.2019.07.002_bib0090","unstructured":"American Psychiatric Association. Manual diagn\u00f3stico y estad\u00edstico de los trastornos mentales: DSM-5: Editorial M\u00e9dica Panamericana; 2014."},{"key":"10.1016\/j.rcp.2019.07.002_bib0095","unstructured":"World Health Organization. Consultation on the development of the global dementia observatory. Geneva: 2017."},{"issue":"10113","key":"10.1016\/j.rcp.2019.07.002_bib0100","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"The Lancet."},{"key":"10.1016\/j.rcp.2019.07.002_bib0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S1041610217002344","article-title":"An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia","volume":"30","author":"Dyer","year":"2018","journal-title":"Int Psychogeriatr."},{"key":"10.1016\/j.rcp.2019.07.002_bib0110","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y tratamiento del trastorno neurocognoscitivo mayor (Demencia). 1.\u00aa ed. Bogot\u00e1: Instituto de Evaluaci\u00f3n Tecnol\u00f3gica en Salud; 2017."},{"key":"10.1016\/j.rcp.2019.07.002_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-150915","article-title":"Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: An-open label, add-on, pilot study","volume":"51","author":"Shelef","year":"2016","journal-title":"J Alzheimer's Dis."},{"key":"10.1016\/j.rcp.2019.07.002_bib0120","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.rcp.2019.07.002_bib0125","doi-asserted-by":"crossref","first-page":"400","DOI":"10.14336\/AD.2015.0617","article-title":"Potential therapeutical contributions of the endocannabinoid system towards aging and Alzheimer's disease","volume":"6","author":"Bonnet","year":"2015","journal-title":"Aging Dis."},{"key":"10.1016\/j.rcp.2019.07.002_bib0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2017.06.116","article-title":"Neurogenesis in the aging brain","volume":"141","author":"Apple","year":"2017","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.rcp.2019.07.002_bib0135","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","article-title":"The endocannabinoid system in normal and pathological brain ageing","volume":"367","author":"Bilkei-Gorzo","year":"2012","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences."},{"key":"10.1016\/j.rcp.2019.07.002_bib0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2010.07.009","article-title":"Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1\u2212\/\u2212 mice","volume":"33","author":"Bilkei-Gorzo","year":"2012","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.rcp.2019.07.002_bib0145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.phrs.2016.07.021","article-title":"Type-2 cannabinoid receptors in neurodegeneration","volume":"111","author":"Bisogno","year":"2016","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.rcp.2019.07.002_bib0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/B978-0-12-800756-3.00095-8","article-title":"Cannabidiol and neuroprotection: Evidence from preclinical studies","author":"Schr\u00f6der","year":"2017","journal-title":"Handbook of cannabis and related pathologies. Elsevier;"},{"key":"10.1016\/j.rcp.2019.07.002_bib0155","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J Alzheimer's Dis."},{"key":"10.1016\/j.rcp.2019.07.002_bib0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-160533","article-title":"Delineating the efficacy of a cannabis-based medicine at advanced stages of dementia in a murine model","volume":"54","author":"Aso","year":"2016","journal-title":"J Alzheimer's Dis."},{"key":"10.1016\/j.rcp.2019.07.002_bib0165","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/B978-0-12-800756-3.00100-9","article-title":"Synthetic cannabinoids in dementia","author":"Amanullah","year":"2017","journal-title":"Handbook of Cannabis and Related Pathologies: Elsevier;"},{"key":"10.1016\/j.rcp.2019.07.002_bib0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2018.01.019","article-title":"Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur J Int Med."}],"container-title":["Revista Colombiana de Psiquiatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034745019300782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034745019300782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:21:25Z","timestamp":1758518485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034745019300782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0034745019300782"],"URL":"https:\/\/doi.org\/10.1016\/j.rcp.2019.07.002","relation":{},"ISSN":["0034-7450"],"issn-type":[{"value":"0034-7450","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids for major neurocognitive disorder: case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Revista Colombiana de Psiquiatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcp.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Asociaci\u00f3n Colombiana de Psiquiatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}